Drug Type Small molecule drug |
Synonyms Anhydrous sodium sulfate, Natrii Sulfus, Natrium Sulfuricum + [10] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaH2Na2O4S |
InChIKeyHJCUCLCJVVFBTD-UHFFFAOYSA-N |
CAS Registry7757-82-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| ST Elevation Myocardial Infarction | Phase 2 | - | 01 Dec 2009 | |
| Coronary Artery Disease | Phase 2 | Australia | 01 May 2009 | |
| Coronary Artery Disease | Phase 2 | Canada | 01 May 2009 | |
| Oxygen radical damage | Phase 2 | Australia | 01 May 2009 | |
| Oxygen radical damage | Phase 2 | Canada | 01 May 2009 | |
| Myocardial Infarction | Phase 2 | - | - | |
| Myocardial Ischemia | Phase 2 | Australia | - | |
| Myocardial Ischemia | Phase 2 | Canada | - | |
| Reperfusion Injury | Phase 2 | Australia | - | |
| Reperfusion Injury | Phase 2 | Canada | - |
Phase 1 | 28 | (Sodium Sulfide - Mild Cohort) | vvpnfuvgat(huoexrelld) = naqpmszoaz ssnjqwbuxg (vihxtldxsk, 57.83) View more | - | 04 Nov 2010 | ||
(Sodium Sulfide - Healthy Cohort) | vvpnfuvgat(huoexrelld) = vizceeusmv ssnjqwbuxg (vihxtldxsk, 100.74) View more |





